Log in | Register

Home
All Journals
Expert Opinion on Biological Therapy
List of Issues
Volume 19, Issue 10

Expert Opinion on Biological Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Biological Therapy, Volume 19, Issue 10 (2019)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 19, Issue 10 (2019)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Volume 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Biosimilars

Editorial

The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases

Carla Felice, Daniela Pugliese & Alessandro Armuzzi

Pages: 967-969

Published online: 11 Jan 2019

First Page PreviewforThe role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases | Full Text | References | PDF (418.5 KB) | EPUB

1144 Views
0 CrossRef citations
0Altmetric

Free Access

Drug Evaluation

Article

CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease

Ahmad Albshesh & Shomron Ben-Horin

Pages: 971-978

Published online: 23 Aug 2019

AbstractforCT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease | Full Text | References | PDF (755 KB) | EPUB

404 Views
6 CrossRef citations
0Altmetric

Article

Ju-Yang Jung, Ji-Won Kim, Hyoun-Ah Kim & Chang-Hee Suh

Pages: 979-986

Published online: 18 Sep 2019

AbstractforRituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | Full Text | References | PDF (1.1 MB) | EPUB

293 Views
5 CrossRef citations
0Altmetric

Article

Clinical development of CT-P6 in HER2 positive breast cancer

Chen Fu, Justin Stebbing & Francisco J. Esteva

Pages: 987-992

Published online: 11 Sep 2019

AbstractforClinical development of CT-P6 in HER2 positive breast cancer | Full Text | References | PDF (605.2 KB) | EPUB

325 Views
3 CrossRef citations
0Altmetric

Review

Lluís Puig & Anna López-Ferrer

Pages: 993-1000

Published online: 01 Jul 2019

AbstractforBiosimilars for the treatment of psoriasis | Full Text | References | PDF (740.6 KB) | EPUB

656 Views
28 CrossRef citations
0Altmetric

Review

Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases

Christopher J. Edwards, Jana Hercogová, Helene Albrand & Aurelian Amiot

Pages: 1001-1014

Published online: 06 May 2019

10506 Views
17 CrossRef citations
0Altmetric

Open Access

Review

Biosimilars for breast cancer

Bruna Migliavacca Zucchetti, Eleonora Nicolò & Giuseppe Curigliano

Pages: 1015-1021

Published online: 10 Jul 2019

AbstractforBiosimilars for breast cancer | Full Text | References | PDF (581.1 KB) | EPUB

333 Views
3 CrossRef citations
0Altmetric

Review

Gionata Fiorino, Daniela Gilardi, Carmen Correale, Federica Furfaro, Giulia Roda, Laura Loy, Marjorie Argollo, Mariangela Allocca, Laurent Peyrin-Biroulet & Silvio Danese

Pages: 1023-1030

Published online: 08 Jan 2019

AbstractforBiosimilars of adalimumab: the upcoming challenge in IBD | Full Text | References | PDF (853.8 KB) | EPUB

790 Views
18 CrossRef citations
0Altmetric

Review

Bioequivalence studies with anti-TNF biosimilars

Mercedes Gimeno-Gracia, Carla J. Gargallo-Puyuelo & Fernando Gomollón

Pages: 1031-1043

Published online: 31 Dec 2018

AbstractforBioequivalence studies with anti-TNF biosimilars | Full Text | References | PDF (1.1 MB) | EPUB

335 Views
5 CrossRef citations
0Altmetric

Review

Wojciech Jurczak, Monika Długosz Danecka & Christian Buske

Pages: 1045-1056

Published online: 30 Sep 2019

AbstractforRituximab biosimilars for lymphoma in Europe | Full Text | References | PDF (1.1 MB) | EPUB

7510 Views
11 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Differences in immunogenicity associated with non-product related variability: insights from two pharmacokinetic studies using GP2017, an adalimumab biosimilar

Oliver von Richter, Lena Lemke, Halimuniyazi Haliduola, Alison Balfour, Britta Zehnpfennig, Andrej Skerjanec & Julia Jauch-Lembach

Pages: 1057-1064

Published online: 19 Apr 2019

755 Views
5 CrossRef citations
0Altmetric

Article

Population pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis

Rameshraja Palaparthy, Muhammad I. Rehman, Oliver von Richter & Donghua Yin

Pages: 1065-1074

Published online: 08 Jul 2019

3006 Views
5 CrossRef citations
0Altmetric

Open Access

Article

GP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods

Oliver von Richter, Lena Lemke, Halimuniyazi Haliduola, Rainard Fuhr, Thomas Koernicke, Ellen Schuck, Maria Velinova, Andrej Skerjanec, Johann Poetzl & Julia Jauch-Lembach

Pages: 1075-1083

Published online: 30 Jan 2019

1399 Views
25 CrossRef citations
0Altmetric

Article

Mechanism of action of the trastuzumab biosimilar CT-P6

Sun Ah Jeong, Jung Min Choi, Jun Mo Park, Jun Young Lee, So Jung Lee, Su Yeon Lee, Si Yeon Lee, Yoon A Park, Hee Jeong Jeong, Yoo Cheol Song, Sung Hwan Kim & Shin Jae Chang

Pages: 1085-1095

Published online: 13 Dec 2018

490 Views
8 CrossRef citations
0Altmetric

Article

Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext)

Stanley B. Cohen, Niklas Czeloth, Eric Lee, Piotr A. Klimiuk, Nuala Peter & Girish Jayadeva

Pages: 1097-1105

Published online: 06 Aug 2019

AbstractforLong-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext) | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental

2885 Views
17 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Biologic therapy for chronic spontaneous urticaria in pediatrics and adolescents: current landscape, challenges, and future perspectives

Katharina Marlies Duda et al.

Review Article | Published online: 17 May 2024

Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature

Emiliano Barbieri et al.

Review Article | Published online: 17 May 2024

Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosis

Yan Jiang et al.

Article | Published online: 16 May 2024

Meta-analysis of response rates to first-line salvage treatment after CAR-T therapy failure in large B-cell lymphoma patients

Jaromir Tomasik et al.

Review Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Biological Therapy (Vol.19, Iss.10, 2019)

Biosimilars

Biosimilars

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?